ALPL

ALPL Overview

English NameAlkaline phosphatase, tissue-nonspecific isozymeApproved Drugs1
Drugs in Clinical Trials3Target SynonymAlkaline Phosphatase, Biomineralization Associated,EC:3.1.3.1,Alkaline Phosphatase Liver/Bone/Kidney Isozyme,Liver/Bone/Kidney-Type Alkaline Phosphatase,ALPL,AP-TNAP,Alkaline Phosphatase, Liver/Bone/Kidney,Tissue Non-Specific Alkaline Phosphatase,TNSALP,Alkaline Phosphatase, Tissue-Nonspecific Isozyme,Tissue-Nonspecific ALP,EC 3.1.3.1,APTNAP,TNALP,TNAP,HOPS
Highest Development StageApproved
English NameAlkaline phosphatase, tissue-nonspecific isozyme
Target SynonymAlkaline Phosphatase, Biomineralization Associated,EC:3.1.3.1,Alkaline Phosphatase Liver/Bone/Kidney Isozyme,Liver/Bone/Kidney-Type Alkaline Phosphatase,ALPL,AP-TNAP,Alkaline Phosphatase, Liver/Bone/Kidney,Tissue Non-Specific Alkaline Phosphatase,TNSALP,Alkaline Phosphatase, Tissue-Nonspecific Isozyme,Tissue-Nonspecific ALP,EC 3.1.3.1,APTNAP,TNALP,TNAP,HOPS
Approved Drugs1
Drugs in Clinical Trials3
Highest Development StageApproved

ALPL Product List

  • Product Category

    Protein (4)

  • Product Status

    Launched (4)

  • Species

    Human (2)Mouse (1)Cynomolgus (1)

  • Tag

    His Tag (4)

  • Conjugate

    Unconjugated (3)HRP Labeled (1)

ALPL Background

This gene encodes a member of the alkaline phosphatase family of proteins. There are at least four distinct but related alkaline phosphatases: intestinal, placental, placental-like, and liver/bone/kidney (tissue non-specific). The first three are located together on chromosome 2, while the tissue non-specific form is located on chromosome 1. The product of this gene is a membrane bound glycosylated enzyme that is not expressed in any particular tissue and is, therefore, referred to as the tissue-nonspecific form of the enzyme. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature enzyme. This enzyme may play a role in bone mineralization. Mutations in this gene have been linked to hypophosphatasia, a disorder that is characterized by hypercalcemia and skeletal defects.

ALPL Synonyms

AP-TNAP, APTNAP, HOPS, HPPA, HPPC, HPPI, HPPO, TNALP, TNAP, TNS-ALP, TNSALP

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
ALXN-1850ALXN-1850Phase 3 ClinicalAlexion Pharmaceuticals IncHypophosphatasia
Details
DS-1211DS-1211Phase 2 ClinicalDaiichi Sankyo Co Ltd, Sanford Burnham Prebys Medical Discovery InstituteOssification, Heterotopic; Pseudoxanthoma Elasticum
Details
ALXN-1910ALXN-1910Phase 1 ClinicalAlexion Pharmaceuticals Inc
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
Asfotase alfasTNALP-FcD10; ALXN-1215; sALP-FcD10; ENB-0040ApprovedAlexion Pharmaceuticals IncStrensiqJapanHypophosphatasiaAlexion Pharmaceuticals Inc2015-07-03Hypophosphatasia
Details
  • Overview
  • Product List
  • Marketed Drug Information
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland